2024-11-17 14:56:00
To further expand the global footprint of its groundbreaking health and wellness applications, Canada-based Myant Corp., a leading provider of advanced healthcare materials, today announced the acquisition of Nanoleq and Osmotex, two leading textile computing companies Based in Switzerland. Zurich has been selected as the headquarters for Myant’s EU and EMEA expansion. These acquisitions will add valuable talent to the company and further consolidate Myant’s leadership position in textile technology. By entering the market and expanding into Europe, Myant is realizing its goal of becoming a global leader in advanced healthcare materials and setting a new standard for connecting people with people and technology.
Nanoleq: a leading Swiss company specializing in smart textiles and biosensor technologies
This strategic acquisition supports Myant’s goal of advancing the future of connected health by integrating Nanoleq’s advanced sensing capabilities into its growing medical device portfolio.
Both companies have a vision to shift the paradigm of healthcare towards prevention and help people by enabling long-term monitoring through textile computer interfaces and clinical data beyond the hospital into the home. Nanoleq’s innovative work in the development of elastic electrical cables, dry electrodes and biosensing technologies is particularly evident in the flagship model Oxa. Oxa allows users to monitor their respiratory function, ECG, heart rate variability (HRV) and stress levels using its state-of-the-art sensor system and receive real-time feedback on their vital signs to improve their physical and mental well-being.
“It is with great enthusiasm that we welcome Nanoleq to the Myant Group,” said Tony Chahine, CEO of Myant. “This acquisition is a critical milestone in our journey to transform healthcare by integrating intelligence into the fabric of everyday life. Health is at the heart of a productive life, and Myant is now ready to further advance the development of innovative personalized medical solutions that enable individuals to proactively monitor their health. The Nanoleq team shares our vision and will support our efforts European and European markets to enter the Middle East will continue to accelerate.”
“Very few companies have succeeded in producing reliable, medically safe, intelligent textiles. Myant’s acquisition of Nanoleq therefore marks an exciting new chapter for us and will help us to significantly scale our activities,” comments Vincent Martinez, CEO at Nanoleq. “The combination of Nanoleq’s expertise in electrically conductive silicones for biosensing With Myant’s medical expertise, this acquisition is a logical step. Both companies agree that our healthcare model is outdated. People need to be empowered to learn about their health before they get sick. All members of our society benefit from improved prevention.
Osmotex: advanced technologies for moisture and fluid management in textiles and medicine
Myant also acquired the technologies of the Swiss deep tech company Osmotex after a joint venture phase. These technologies enable precise control of moisture and particles in individual microchannels as well as in membranes and textiles with billions of such channels or pores.
For textiles and garments, the technology offers an “electronically controlled breathable membrane” that can withstand human sweat rates in the most extreme conditions. This innovation represents a breakthrough for protective clothing and first aid clothing. It acts like a second skin and increases the physiological comfort, performance and safety of the wearer.
In the medical field, Osmotex fabrics will similarly be used as a second skin for optimal wound healing and as next-generation drug delivery systems. Diagnostic applications through the collection, separation and analysis of liquids are also being developed.
“The Osmotex technology is a milestone in the field of moisture and fluid management,” reports Tony Chahine, CEO at Myant. “The technology acts like a second skin and directly influences the physiological and microclimatic conditions of the wearer. Whether in intelligent wound dressings for a rapid healing or in firefighter uniforms to avoid dangerous heat exposure – it removes the limitations of current variants that extract moisture directly from the air, opening up further possibilities, with significant potential for energy savings and reduction of material wear.”
“With Myant, we are now able to maximize the benefits of our technologies,” explains Trond Heldal, CEO of Myant Swiss and former CEO of Osmotex. “We have developed a unique solid-state pump technology based on state-of-the-art materials science and technology “In Myant, we have gained an equally unique partner who covers the value chain from its 17,000 square meter state-of-the-art materials laboratories through manufacturing to integration into a variety of finished products and services.”
About Myant Corp
Myant’s goal is to enable and improve quality of life for everyone. We leverage advances in AI, medicine and advanced materials to promote health, safety, connection and confidence at every stage of life.
Myant is leading a new era of evolution in which AI guardians enhance human capabilities using textile interfaces that function like a connected second skin. Made from groundbreaking modern materials, this second skin blends naturally into our everyday lives and sets new standards for seamless interaction with the digital world.
From birth to old age, AI guardians enrich our daily lives, promote our well-being, keep us safe, redefine how we connect with society, and enable universal access to the best possible care at all times.
In 2024, Myant expanded into the EU with significant growth and brought on world-renowned AI scientist Dr. Xin Gao on board as Chief AI Officer.
For more information, see www.myant.ca.
Information about Nanoleq
Nanoleq is a leading Swiss company for state-of-the-art, flexible and elastic electrical connections, dry electrodes and biosensor technologies. Its flagship product, Oxa, is a smart wearable that tracks respiratory health, ECG, heart rate variability and other physiological markers, providing actionable data on health and well-being.
For more information, see www.nanoleq.com.
Information about Osmotex
Osmotex, a Swiss technology company, has developed and patented innovative technologies for the controlled transport of moisture in micropores, membranes and textiles. The product range includes microfluidic pumps for life sciences, wound care and medical applications as well as air-conditioned clothing for sports. These innovations were developed over several years in close collaboration with leading Swiss universities and research institutes and are protected by a solid patent portfolio.
Consumer Electronic Show (CES) 2025
From January 7-10, 2025, Myant will be at booth 53618 at the Venetian Expo & Convention Center, 201 Sands Ave. in Las Vegas, NV 89169, USA.
1731879452
#Myant #Acquires #Nanoleq #Osmotex #Technologies #Strengthening #Leadership #Advanced #Materials #Textile
What are the key technologies acquired from Nanoleq and Osmotex that will impact Myant’s health monitoring solutions?
**Interview with Tony Chahine, CEO of Myant Corp**
*Date: November 17, 2024*
**Interviewer:** Thank you for joining us today, Tony. Myant has just made headlines with the acquisition of two innovative companies, Nanoleq and Osmotex. Can you explain how these acquisitions will enhance Myant’s mission in the health and wellness space?
**Tony Chahine:** Absolutely, and thank you for having me. Acquiring Nanoleq and Osmotex is a pivotal step for Myant. Both companies bring expertise that aligns perfectly with our goal of transforming healthcare through connected technologies. Nanoleq’s advanced sensing capabilities complement our medical device portfolio, enabling long-term health monitoring. Meanwhile, Osmotex’s moisture management technologies will revolutionize how we approach not just health monitoring, but also protective clothing and wound care.
**Interviewer:** That sounds promising! Could you elaborate on how Nanoleq’s products, specifically the Oxa model, fit into this vision?
**Tony Chahine:** Certainly! The Oxa model serves as a prime example of our commitment to proactive health management. It allows users to monitor vital metrics such as respiratory function and heart rate in real time. This is about empowering individuals to take control of their health before issues arise. Integrating such capabilities into everyday clothing will redefine the relationship people have with their health data.
**Interviewer:** And what about Osmotex? How does its technology enhance Myant’s offerings?
**Tony Chahine:** Osmotex’s technology is groundbreaking—it utilizes electronically controlled breathable membranes that react to environmental conditions, enhancing physiological comfort and safety. In medical applications, it can facilitate optimal wound healing and serve as a platform for next-generation drug delivery systems. This capability to manage moisture and temperature can significantly change how we approach both everyday clothing and medical textiles.
**Interviewer:** Myant is focusing on the European and EMEA markets with this acquisition. What does this mean for your expansion strategy?
**Tony Chahine:** Establishing our headquarters in Zurich is a strategic move to position ourselves strongly in the European market. We believe that the demand for connected health solutions will continue to grow, especially in Europe. This expansion will allow Myant to harness local talent, collaborate closely with European innovators, and ultimately enhance our offerings to consumers around the world.
**Interviewer:** what excites you most about the future following these acquisitions?
**Tony Chahine:** I’m thrilled about the potential we have to shift the healthcare paradigm from reactive to proactive. By leveraging advanced materials and AI technology through textile interfaces, we’re not just creating products; we’re fostering a new way of life that prioritizes health and well-being. It gives us a chance to truly redefine how people interact with their health, making it more accessible and integrated into their daily lives.
**Interviewer:** Thank you, Tony, for sharing these insights. We look forward to seeing how Myant continues to innovate and lead in this space!
**Tony Chahine:** Thank you for having me! We’re excited about the journey ahead.